containing target protein, we established stable MH7A cell lines overexpressing GFP-tagged PLCH2. We also conducted in vitro and in vivo experiments using a recombinant adenovirus expressing the full length form of PLCH2 or C2 domain of PLCH2 (C2-PLCH2). Results Several C2 domain-containing proteins were identified whose over-expression resulted in reduced proliferation and NF-kB activity of RA-FLS. Among those, we focused on PLCH2 in this study. PLCH2 levels were significantly decreased in RA-FLS and synovium than OA. PLCH2 and C2-PLCH2 suppressed cell invasion and migration, cytokines production, and matrix metalloproteinase secretion in RA-FLS and stable MH7A cell lines compared to control. PLCH2 and C2-PLCH2 sensitised RA-FLS to apoptosis in vitro and in vivo model of matrigel implants engrafted into immunodeficient mice. PLCH2 and C2-PLCH2 further decreased arthritis severity in collagen-induced arthritis (CIA) mouse model. Conclusions Our results showed that invasive characteristics of RA-FLS and inflammatory arthritis of CIA are reduced by PLCH2 and C2 domain of PLCH2. Therefore C2 domain of PLCH2 may have therapeutic potential for RA.
Introduction CD4 +T cells in rheumatoid arthritis (RA) display a peculiar restriction of the T-cell receptor (TCR) repertoire which compromises their ability to react to novel antigens. 1 We demonstrated that this process could be partially reverted by abatacept (ABA), which is a blocker of T lymphocyte costimulation, used in the treatment of RA. 2 To better understand the mechanisms underlying this phenomenon, we speculated that ABA could influence the frequency of peripheral T cell subpopulations, even at early stages of maturation.
The homeostasis of the naïve T cell pool is maintained not only by thymus production, but also by mechanisms of peripheral replication involving TCR activation revealed by CD31 down-modulation. Indeed, CD4+CD45RA+CD31+T cells have been described as recent thymic emigrants (RTE) newly produced by the thymus and CD4+CD45RA+CD31 T cells as central naïve, involved in a self-renewal peripheral process. Objectives We aimed at profiling circulating naïve CD4 +CD45RA+T cells, by assessing their expression of CD31 (PECAM-1). Conclusions The number of total naïve T cells increases after therapy with ABA together with the number of RTE, suggesting a thymic output boost. Besides the peripheral effect in reducing the number of effector T cells which was showed by previous studies,
